Genentech Recalls Prescription Drug Evrysdi Due to Failure to Meet Child Resistant Packaging Requirements; Risk of Drug Exposure through Eye or Skin Absorption (Recall Alert)
CPSC recall 21729. Recall date: .
Hazard, in the words of CPSC
The bottles containing the prescription drug can leak due to a fit issue between the press-in bottle adapter and bottleneck. If the bottle is leaking, there is a risk of drug exposure by contact with skin or eyes. Prescription drugs must be in child resistant packaging that prevents children from gaining access to the contents as required by the Poison Prevention Packaging Act (PPPA).
Remedy, in the words of CPSC
Consumers should immediately store Evrysdi in a safe location out of reach and sight of children. Consumers should inspect the bottle for any leaking. If it is leaking, contact Genentech for a free replacement. Consumers can continue to use as directed, as the leakage is not anticipated to impact the safety or efficacy of administered medicine. If Evrysdi gets on your skin, wash the area with soap and water. If Evrysdi gets in your eyes, rinse your eyes with water. Genentech is contacting all known purchasers directly.
CPSC recall 21729 has the recall date 18 Mar 2021. The notice names the firm Genentech, a member of the Roche Group. The recall has about 14,000 units. The median CPSC recall of 2021 has 7,850 units. This register puts the recall under the hazard Poisoning.
Federal law prohibits any person from selling products subject to a Commission ordered recall or a voluntary recall undertaken in consultation with the CPSC.
CPSC publishes these words. Source: CPSC recall notices, section About the U.S. CPSC, read on . The hazard, the remedy and the incident text on this site are the words of the CPSC recall notice. Newest CPSC recall on the register: .
More of the notice
The hazard and the remedy are at the top of the page. Each quotation is the text of CPSC.
| Incidents and injuries | Genentech has received 26 reports of leaking bottles. No injuries have been reported. |
|---|---|
| Units | 14,000 |
| Remedy options | Replace |
| Description | This recall involves bottles of the prescription drug Evrysdi, a prescription medicine used to treat spinal muscular atrophy (SMA) in adults and children 2 months of age and older. The recalled 100 mL amber bottles have "Evrysdi (risdiplam) for oral solution," the dosage and "NDC 20242-175-07" on the front of the bottle labels. |
| Product | Evrysdi™ (risdiplam), About 14,000 |
| Sold at | Select specialty pharmacies nationwide as a prescribed medicine from August 2020 through the present. The price of the medication varies based on health insurance terms and other factors. |
| Manufacturer | Genentech, a member of the Roche Group |
| Made in | Switzerland |
Recall notice: The page that CPSC publishes for one recall of a consumer product. It states the product, the hazard, the remedy and the incidents.
Hazard: The way a product can cause harm, in the words of the CPSC recall notice. This site also puts each recall under short hazard names.
Remedy: What the manufacturer or the firm does about a recalled product. The agency record states the remedy of each recall.
Units: The number of vehicles or products that a recall can include. The manufacturer or the firm reports the number to the agency.
The recall in context
- Units in this recall
- 14,000Median of 2021: 7,850
- CPSC recalls of 2021
- 219
- Recalls of 2021 with one of the same hazards
- 11%
- Recalls on the register that name Genentech, a member of the Roche Group
- 1
Official channels
- CPSC recall notice 21729The notice on the CPSC site, with the pictures and the contact of the firm.
- CPSC recallsThe list of all recall notices on the CPSC site.
- SaferProducts.govThe CPSC site for a report about a consumer product.
Follow by RSS:Consumer product recalls
Cite this page
Recall Register. CPSC recall 21729. https://recallregister.com/product/9021-genentech-recalls-prescription-drug-evrysdi-due-to-failure-to-meet-chi/. Source: CPSC Recall Retrieval Web Services. Data through .
Sources
- Source
- US Consumer Product Safety Commission
- Licence
- US government work, public domain
- Data retrieved
- 30 Sep 2026
- Newest CPSC recall on the register
- 24 Sep 2026
The CPSC notice is the authority. The hazard names come from the hazard text of CPSC. The category is the product type that CPSC gives. How the register is made. Report an error.
Questions
- Does CPSC recall 21729 report injuries?
- The CPSC notice says:
Genentech has received 26 reports of leaking bottles. No injuries have been reported.
- Where was the product sold?
- The CPSC notice says:
Select specialty pharmacies nationwide as a prescribed medicine from August 2020 through the present. The price of the medication varies based on health insurance terms and other factors.
- Which remedy options does CPSC list for recall 21729?
- CPSC lists 1 remedy option:
Replace
- How many units are in CPSC recall 21729?
- The CPSC notice gives this number:
About 14,000